Following The Money: Institution’s Growing Stake In Revelation Biosciences Inc (NASDAQ: REVB)
Revelation Biosciences Inc (REVB) concluded trading on Wednesday at a closing price of $2.09, with 85.27 million shares of worth about $178.22 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.65% during that period and on August 21, 2024 the price saw a […]
Following The Money: Institution’s Growing Stake In Revelation Biosciences Inc (NASDAQ: REVB)
Walleye Capital LLC has recently announced that it has increased stake in Revelation Biosciences Inc (NASDAQ:REVB) by 26.60%. After grabbing 0.39 million shares, the institutional investor is now in possession of 82219.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.22% having worth around $0.2 million. Moreover, Citadel […]